|
|
|
| |
|
 |
|
|
| [VIS PATENT] |
| |
| |
|
|
| Ansøgningsnr. og dato | 15852227.6 (espacenet) (Federated) (European Patent Register), 20151019 | | Patent/reg.nr. og dato | DK/EP 3209767, 20200805 | | Tilgængelighedsdato | 20170830 | | Prioritetsnr. og dato | IN 2343MU2014, 20141021 | | EP publ. nr. og dato |
EP 3209767 20170830 | | Løbedag | | | Ansøger/indehaver | Gennova Biopharmaceuticals Ltd., P-1 IT-BT Park MIDC Phase-2
Hinjwadi, Pune - 411057, IN | | Ansøgers ref. nr. | V2010-009-DK | | Opfinder | RAGHUWANSHI, Arjun, GENNOVA Vaccine Formulation Centre and
Research Laboratory BTS-2 Building
Chrysalis Enclave Block-2 Plot-2
International Biotech Park
Phase II MIDC Hinjwadi
Pune
Maharashtra 411057, IN,
SINGH KUMAR, Shrawan, GENNOVA Vaccine Formulation Centre and
Research Laboratory BTS-2 Building
Chrysalis Enclave Block-2 Plot-2
International Biotech Park
Phase II MIDC Hinjwadi
Pune
Maharashtra 411057, IN,
KUMAR, Ankit, GENNOVA Vaccine Formulation Centre and
Research Laboratory BTS-2 Building
Chrysalis Enclave Block-2 Plot-2
International Biotech Park
Phase II MIDC Hinjwadi
Pune
Maharashtra 411057, IN,
SAHOO RANJAN, Mihir, GENNOVA Vaccine Formulation Centre and
Research Laboratory BTS-2 Building
Chrysalis Enclave Block-2 Plot-2
International Biotech Park
Phase II MIDC Hinjwadi
Pune
Maharashtra 411057, IN,
SINGH, Sanjay, GENNOVA Vaccine Formulation Centre and
Research Laboratory BTS-2 Building
Chrysalis Enclave Block-2 Plot-2
International Biotech Park
Phase II MIDC Hinjwadi
Pune
Maharashtra 411057, IN | | Fuldmægtig | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Interessent på tilknyttet sag | | | IPC-Klasse | C12N 1/14 (2006.01) | | Titel/benævnelse | HIDTIL UKENDT OPRENSNINGSFREMGANGSMÅDE TIL ISOLERING OG KOMMERCIEL FREMSTILLING AF REKOMBINANT TNK-TPA (TENECTEPLASE) | | Internationalt ansøgningsnr. | IN2015050137 | | Internationalt publ. nr. | WO2016063299 | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
